Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
INVENTIVA : Exercice 2017 - Informations financières et point sur l'activité
February 12, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva : Exercice 2017...
INVENTIVA: Full-Year 2017 Financial Information and Business Update
February 12, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva Full-Year 2017Financial...
INVENTIVA: Half-yearly review and termination of a liquidity contract with Oddo BHF and implementation of a new liquidity contract with Kepler Cheuvreux
February 01, 2018 01:30 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Half-yearly review and termination of a...
INVENTIVA : Bilan semestriel et résiliation du contrat de liquidité avec Oddo BHF et mise en oeuvre d'un nouveau contrat de liquidité avec Kepler Cheuvreux
February 01, 2018 01:30 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
Inventiva to present in vivo data with odiparcil at the 14th WORLDSymposium(TM)
January 31, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva to present in vivo data with...
Inventiva présentera des données in vivo sur odiparcil lors du 14ème WORLDSymposium
January 31, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva présentera des données in vivo...
INVENTIVA : Inventiva Announces Positive DSMB Review in Phase IIb FASST Trial in Systemic Sclerosis with Lanifibranor
January 04, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva Announces Positive DSMB...
INVENTIVA : Inventiva Annonce les Conclusions Positives du DSMB de l'Etude de Phase IIb FASST dans la Sclérodermie Systémique avec le Lanifibranor
January 04, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
Inventiva Announces Enrollment of First Patient into Its Odiparcil Phase IIa Trial (iMProveS) for MPS VI
January 03, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Inventiva Announces Enrollment of...
Inventiva annonce l'inclusion du premier patient dans son étude de phase IIa (iMProveS) menée avec odiparcil dans le traitement de la MPS VI
January 03, 2018 11:45 ET
|
INVENTIVA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...